Jardin D'Hiver
GĂ©raldine Biard Wednesday 12 Aug 2015

Géraldine Biard is a product and furniture designer from France who recently graduated with an MA in Furniture Design from Central Saint Martin’s College of Art & Design. She created a range of furniture for relaxation using aromatherapy and light therapy. In her work Biard engages the user’s sight, smell and tactile senses. She uses the translucent and resistant qualities of Corian® to design the top section of her pieces. Her design evokes an open window into a snow covered landscape, where the aromatherapy emanates from a sculpted mountain with sensual curves, and the light therapy lamp diffuses behind a graphic scenery.

Jardin d’Hiver uses elegance and innovation as key criteria to question medical design conventions and establish new standards for design excellence in healthcare. ‘With this collection I aimed to establish new standards for healthcare design and invite designers across the globe to consider the growing problem of dementia. I worked with people with dementia in Switzerland and I noticed that in addition to anxiety caused by the disease, the care environment itself can be another source of stress for the residents. With no medical cure, for me the best way to soothe and revitalize the individuals’ life was by using relaxation through design. Each piece of furniture from Jardin d’Hiver will act as a companion that will join us during every step of the journey.’ explains Biard.

This collection of furniture is composed of two bedside cabinets, a credenza and a console table, integrating an aroma diffuser and a light therapy lamp to alleviate anxiety and the different sleep disturbances associated to dementia.

According to the World Health Organization, the number of people with dementia worldwide is 47,5million and will increase to over 135,5 million in 2050. Inside the UK, there are 850,000 dementia sufferers and the latest projections of The Alzheimer’s Society show that this number will increase to over 2 million by 2051. In 2010, the total societal cost of dementia in the world was estimated at $604 billion.